RLY-4008 HCl

RLY-4008 HCl is a novel potent and highly selective FGFR2 inhibitor designed to overcome the emergence of on-target FGFR2 resistance mutations and dose-limiting toxicities associated with current pan-FGFR inhibitors. RLY-4008 HCl is > 200-fold selective over FGFR1, and > 80- and > 5000-fold selective over FGFR3 and FGFR4, respectively.


Cat. No.: EX-A6478A	Purity: >98%

	Chemical structure of RLY-4008 HCl

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
250mg	1150	In-stock
500mg	1750	In-stock
1g	2550	In-stock
2g	get quote	In-stock
3g	get quote	In-stock
5g	get quote	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


Synonyms	RLY-4008 hydrochloride
Synonyms 2	Lirafugratinib hydrochloride
CAS No.	2688040-45-9
Purity	>98%
Formula	C28H25ClFN7O2
Mol Weight	545.995
Color	Light brown to brown
State	solid powder
Solubility	Soluble in DMSO 125 mg/mL
Shelf Life	>3 years if stored properly
Storage	Powder -20℃ 3 years, 4°C 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. [1] Lescarbeau, Andre, et al. Preparation of substituted pyrrolopyrimidines as FGFR inhibitors and methods of making and using the same. WO2022109577.
Data Sheet	Data sheet of RLY-4008 HCl
CoA	CoA of RLY-4008 HCl
SDS	SDS of RLY-4008 HCl


		Search